8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001104659-18-011575
Material agreement · Acquisition or sale completed
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
From the SEC's structured data for this filing
Loading a18-6438_18k.htm…